- Home
- CBNK vs ETON Comparison
CBNK vs ETON Comparison
Compare CBNK & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBNK
- ETON
- Stock Information
- Founded
- CBNK 1974
- ETON 2017
- Country
- CBNK United States
- ETON United States
- Employees
- CBNK N/A
- ETON N/A
- Industry
- CBNK Major Banks
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- CBNK Finance
- ETON Health Care
- Exchange
- CBNK Nasdaq
- ETON Nasdaq
- Market Cap
- CBNK 471.8M
- ETON 428.5M
- IPO Year
- CBNK 2018
- ETON 2018
- Fundamental
- Price
- CBNK $31.46
- ETON $13.57
- Analyst Decision
- CBNK Hold
- ETON Strong Buy
- Analyst Count
- CBNK 1
- ETON 3
- Target Price
- CBNK $35.00
- ETON $29.67
- AVG Volume (30 Days)
- CBNK 60.1K
- ETON 465.6K
- Earning Date
- CBNK 07-21-2025
- ETON 08-07-2025
- Dividend Yield
- CBNK 1.27%
- ETON N/A
- EPS Growth
- CBNK 6.54
- ETON N/A
- EPS
- CBNK 2.49
- ETON N/A
- Revenue
- CBNK $188,910,000.00
- ETON $48,327,000.00
- Revenue This Year
- CBNK $46.92
- ETON $103.21
- Revenue Next Year
- CBNK $7.82
- ETON $51.34
- P/E Ratio
- CBNK $12.62
- ETON N/A
- Revenue Growth
- CBNK 20.92
- ETON 40.88
- 52 Week Low
- CBNK $19.45
- ETON $3.18
- 52 Week High
- CBNK $34.31
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- CBNK 48.37
- ETON 26.42
- Support Level
- CBNK $30.83
- ETON $13.20
- Resistance Level
- CBNK $32.61
- ETON $19.35
- Average True Range (ATR)
- CBNK 0.59
- ETON 0.93
- MACD
- CBNK -0.17
- ETON -0.49
- Stochastic Oscillator
- CBNK 36.46
- ETON 6.02
About CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.